Press Releases
Stay informed with the latest news and updates from the California Institute for Regenerative Medicine (CIRM). For media inquiries or additional information, contact the CIRM communications team at press@cirm.ca.gov. For even more breaking news, visit our blog, The Stem Cellar.
October 19, 2016
CIRM Creates World’s First “Translating Center” to Dramatically Accelerate Stem Cell Research
CIRM Creates World’s First “Translating Center” to Dramatically Accelerate Stem Cell Research
September 21, 2016
Rare, Life-Threatening Childhood Disease is the Focus of CIRM’s Most Recent Investment
Rare, Life-Threatening Childhood Disease is the Focus of CIRM’s Most Recent Investment
July 21, 2016
CIRM Invests $10 Million in Clinical Trial to Improve Dialysis and $13.6 Million for Promising Early Research Projects
CIRM Invests $10 Million in Clinical Trial to Improve Dialysis and $13.6 Million for Promising Early Research Projects
February 18, 2016
CIRM Invests in Treatment Focused on High Risk Blood Cancers, Leukemia and Lymphoma
CIRM Invests in Treatment Focused on High Risk Blood Cancers, Leukemia and Lymphoma
January 6, 2016
Important Update Regarding CIRM’s Partnered Clinical Trial for Patients with Metastatic Melanoma
Important Update Regarding CIRM’s Partnered Clinical Trial for Patients with Metastatic Melanoma
December 17, 2015
Stem Cell Board Sends “Strong, Unambiguous Message”; Approves Bold New Vision for the Future
Stem Cell Board Sends “Strong, Unambiguous Message”; Approves Bold New Vision for the Future
September 24, 2015
Stem Cell Agency Invests Almost $20 Million in Clinical Trial for Deadly Brain Cancer
Stem Cell Agency Invests Almost $20 Million in Clinical Trial for Deadly Brain Cancer
July 1, 2015
CIRM Completes Reorganization with the Appointment of Three Highly Talented Individuals to its Leadership Team
CIRM Completes Reorganization with the Appointment of Three Highly Talented Individuals to its Leadership Team
February 25, 2015
CIRM-funded Program Invests More Than $11 Million in Stem Cell Genomics Research Collaborations
CIRM-funded Program Invests More Than $11 Million in Stem Cell Genomics Research Collaborations
December 11, 2014
Stem Cell Agency Board Approves $50 Million for CIRM 2.0, a “Radical Overhaul” of How it Drives Development of Stem Cell Treatments
Stem Cell Agency Board Approves $50 Million for CIRM 2.0, a “Radical Overhaul” of How it Drives Development of Stem Cell Treatments
December 1, 2014
Stem Cell Agency & Israel Announce International Collaboration to Advance Stem Cell Research
Stem Cell Agency & Israel Announce International Collaboration to Advance Stem Cell Research
November 19, 2014
Poland and California Announce International Collaboration to Advance Stem Cell Research toward Cures
Poland and California Announce International Collaboration to Advance Stem Cell Research toward Cures
September 17, 2014
Stem Cell Agency Invests $16 million To Fight Diabetes and Announces Plan to Launch CIRM 2.0
Stem Cell Agency Invests $16 million To Fight Diabetes and Announces Plan to Launch CIRM 2.0
August 26, 2014
Treatment for Spinal Cord Injury To Start Clinical Trial Funded by California’s Stem Cell Agency
Treatment for Spinal Cord Injury To Start Clinical Trial Funded by California’s Stem Cell Agency
August 21, 2014
World’s Largest Pharmaceutical Company Signs Agreement with ViaCyte for a Stem Cell Treatment for Type 1 Diabetes
World’s Largest Pharmaceutical Company Signs Agreement with ViaCyte for a Stem Cell Treatment for Type 1 Diabetes
August 19, 2014
Type 1 Diabetes Treatment Funded by California Stem Cell Agency Cleared To Begin Clinical Trial
Type 1 Diabetes Treatment Funded by California Stem Cell Agency Cleared To Begin Clinical Trial
August 12, 2014
Dr. David Higgins appointed as Patient Advocate for Parkinson’s disease to Stem Cell Agency Board
Dr. David Higgins appointed as Patient Advocate for Parkinson’s disease to Stem Cell Agency Board
July 17, 2014
Type 1 Diabetes Therapy Funded by Stem Cell Agency Submits Application to Start Clinical Trial
Type 1 Diabetes Therapy Funded by Stem Cell Agency Submits Application to Start Clinical Trial
July 9, 2014
Statement Regarding Former CIRM President’s New Position on a Stem Cell Company’s Board
Statement Regarding Former CIRM President’s New Position on a Stem Cell Company’s Board
May 29, 2014
Stem Cell Agency Invests $32 Million Toward Therapies For Spinal Cord Injury and HIV/AIDS
Stem Cell Agency Invests $32 Million Toward Therapies For Spinal Cord Injury and HIV/AIDS
March 13, 2014
Stem Cell Agency Approves $72 million to Accelerate Promising Projects Toward the Clinic
Stem Cell Agency Approves $72 million to Accelerate Promising Projects Toward the Clinic
